Lenacapavir works as pre-exposure prophylaxis (PrEP) and is the first and only FDA-approved injectable PrEP that offers six months of protection per dose. Kenya is one of nine African countries ...
The Rwanda Biomedical Center (RBC) said last week that the government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the year. ALSO READ: ...
The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the year, according to Rwanda Biomedical Centre (RBC). The injection, given once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results